IPG
42
3
PEG
71
-3
EQIX
62
3
HP
45
4
EMR
60
3
APA
28
3
MDT
55
3
PDCO
58
3
WMT
63
-3
THC
64
3
CF
60
3
AVGO
49
9
AMG
44
3
GD
59
2
DLTR
28
-3
TXN
53
3
PG
48
-3
MSFT
57
3
MRK
50
-3
PX
56
4
IPG
42
3
PEG
71
-3
EQIX
62
3
HP
45
4
EMR
60
3
APA
28
3
MDT
55
3
PDCO
58
3
WMT
63
-3
THC
64
3
CF
60
3
AVGO
49
9
AMG
44
3
GD
59
2
DLTR
28
-3
TXN
53
3
PG
48
-3
MSFT
57
3
MRK
50
-3
PX
56
4
Financhill
Back

Clearfield 10K Form

Sell
42

CLFD
Clearfield

Last Price:
40.68
Seasonality Move:
-1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLFD News And Ratings

See the #1 stock for the next 7 days that we like better than CLFD

CLFD Financial Statistics

Sales & Book Value

Annual Sales: $268.72M
Cash Flow: $2.65M
Price / Cash Flow: 80.14
Annual Sales: $19.28
Price / Book: 2.11

Profitability

EPS (TTM): -0.63000
Net Income (TTM): $-8.93M
Gross Margin: $85.28M
Return on Equity: -3.02%
Return on Assets: -2.65%

Clearfield Earnings Forecast

Key Clearfield Financial Ratios

  • The Gross Profit Margin over the past 35 years for CLFD is 31.74%.
  • The Selling, General & Administrative Expenses for CLFD have been equal to 17.86% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 2.71% of Operating Income.
  • The Net Earning history of CLFD is 12.11% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 19 years.

Clearfield Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Communications Equipment
Sector: Information Technology
Current Symbol: CLFD
CUSIP: 18482P
Website: seeclearfield.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 8.38
Quick Ratio: 5.38

Price-to-Earnings

Trailing P/E Ratio: 18.74
Forward P/E Ratio: 301.26

CLFD Technical Analysis vs Fundamental Analysis

Sell
42
Clearfield (CLFD) is a Sell

Is Clearfield a Buy or a Sell?

  • Clearfield stock is rated a Sell
    The current Clearfield [CLFD] share price is $40.67. The Score for CLFD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.